Latest PLX reports update at 2024-03-14: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. Protalix BioTherapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.25 9.65%
mail-toReport an Error

Protalix BioTherapeutics EV/EBITDA Ratio 2011-2024 | PLX

Annual EV/EBITDA Ratio Protalix BioTherapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.1 45.9 -9.68 -4.08 -2.66 -2.44 -3.59 -9 -16.3 -47.7 -13.2

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
45.9 -47.7 -5.9